Next Article in Journal
HTLV-1 Infection and Pathogenesis: New Insights from Cellular and Animal Models
Previous Article in Journal
Human Mitochondrial RNA Processing and Modifications: Overview
Previous Article in Special Issue
Uncovering the Mechanisms of Adenosine Receptor-Mediated Pain Control: Focus on the A3 Receptor Subtype
Article

Istradefylline Mitigates Age-Related Hearing Loss in C57BL/6J Mice

1
Department of Physiology and The Eisdell Moore Centre, Faculty of Medical and Health Sciences, The University of Auckland, Private Bag, Auckland 1142, New Zealand
2
Centre for Brain Research, Faculty of Medical and Health Sciences, The University of Auckland, Private Bag, Auckland 1023, New Zealand
*
Author to whom correspondence should be addressed.
Academic Editor: Katia Varani
Int. J. Mol. Sci. 2021, 22(15), 8000; https://doi.org/10.3390/ijms22158000
Received: 11 June 2021 / Revised: 23 July 2021 / Accepted: 23 July 2021 / Published: 27 July 2021
Age-related hearing loss (ARHL) is the most common sensory disorder among older people, and yet, the treatment options are limited to medical devices such as hearing aids and cochlear implants. The high prevalence of ARHL mandates the development of treatment strategies that can prevent or rescue age-related cochlear degeneration. In this study, we investigated a novel pharmacological strategy based on inhibition of the adenosine A2A receptor (A2AR) in middle aged C57BL/6 mice prone to early onset ARHL. C57BL/6J mice were treated with weekly istradefylline (A2AR antagonist; 1 mg/kg) injections from 6 to 12 months of age. Auditory function was assessed using auditory brainstem responses (ABR) to tone pips (4–32 kHz). ABR thresholds and suprathreshold responses (wave I amplitudes and latencies) were evaluated at 6, 9, and 12 months of age. Functional outcomes were correlated with quantitative histological assessments of sensory hair cells. Cognitive function was assessed using the Morris water maze and the novel object recognition test, and the zero maze test was used to assess anxiety-like behaviour. Weekly injections of istradefylline attenuated ABR threshold shifts by approximately 20 dB at mid to high frequencies (16–32 kHz) but did not improve ABR suprathreshold responses. Istradefylline treatment improved hair cell survival in a turn-dependent manner, whilst the cognitive function was unaffected by istradefylline treatment. This study presents the first evidence for the rescue potential of istradefylline in ARHL and highlights the role of A2AR in development of age-related cochlear degeneration. View Full-Text
Keywords: age-related hearing loss; cognitive function; adenosine A2A receptor; istradefylline; otoprotection; C57BL/6 mouse age-related hearing loss; cognitive function; adenosine A2A receptor; istradefylline; otoprotection; C57BL/6 mouse
Show Figures

Figure 1

MDPI and ACS Style

Shin, M.; Pandya, M.; Espinosa, K.; Telang, R.; Boix, J.; Thorne, P.R.; Vlajkovic, S.M. Istradefylline Mitigates Age-Related Hearing Loss in C57BL/6J Mice. Int. J. Mol. Sci. 2021, 22, 8000. https://doi.org/10.3390/ijms22158000

AMA Style

Shin M, Pandya M, Espinosa K, Telang R, Boix J, Thorne PR, Vlajkovic SM. Istradefylline Mitigates Age-Related Hearing Loss in C57BL/6J Mice. International Journal of Molecular Sciences. 2021; 22(15):8000. https://doi.org/10.3390/ijms22158000

Chicago/Turabian Style

Shin, Min, Madhavi Pandya, Kristan Espinosa, Ravindra Telang, Jordi Boix, Peter R. Thorne, and Srdjan M. Vlajkovic 2021. "Istradefylline Mitigates Age-Related Hearing Loss in C57BL/6J Mice" International Journal of Molecular Sciences 22, no. 15: 8000. https://doi.org/10.3390/ijms22158000

Find Other Styles
Note that from the first issue of 2016, MDPI journals use article numbers instead of page numbers. See further details here.

Article Access Map by Country/Region

1
Back to TopTop